• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

供体风险指数、ECD评分和D-MELD评分均无法以可接受的敏感性和特异性预测肝移植后的短期预后。

The Donor-Risk-Index, ECD-Score and D-MELD-Score all fail to predict short-term outcome after liver transplantation with acceptable sensitivity and specificity.

作者信息

Schrem Harald, Reichert Benedikt, Frühauf Nils, Becker Thomas, Lehner Frank, Kleine Moritz, Bektas Hüseyin, Zachau Lea, Klempnauer Jürgen

机构信息

General, Visceral and Transplantation Surgery, Hannover Medical School, Hannover, Germany.

出版信息

Ann Transplant. 2012 Jul-Sep;17(3):5-13. doi: 10.12659/aot.883452.

DOI:10.12659/aot.883452
PMID:23018250
Abstract

BACKGROUND

Expansion of the donor pool by the use of grafts with extended donor criteria reduces waiting list mortality with an increased risk for graft and patient survival after liver transplantation. This study investigates the ability of the Donor-Risk-Index (DRI), the Extended-Criteria-Donor-Score (ECD-score) and the D-MELD-score to predict early outcome after liver transplantation.

MATERIAL/METHODS: 291 consecutive adult liver transplants (01.01.2007-31.12.2010) were analysed in a single centre study with ongoing data collection. Primary study endpoints were 30-day mortality, 3-month mortality, 3-month patient and graft survival and the necessity of acute retransplantation within 30 days. For the primary study endpoints ROC-curve analysis was performed to calculate the sensitivity, specificity, and overall model correctness of the Donor-Risk-Index (DRI), Extended-Criteria-Donor-Score (ECD-score) and the D-MELD-Score as predictive models. Cut-off values were selected with the best Youden index.

RESULTS

ROC-curve analysis showed areas under the curve (AUROCs) <0.7 for the DRI, the ECD-Score and the D-MELD-Score as models for the prediction of 30-day mortality, 3-month mortality, 3-month patient survival, 3-month graft survival as well as the necessity of acute retransplantation within 30 days after transplantation with unacceptable low levels of overall model correctness (<62%) and specificity (<56%).

CONCLUSIONS

The DRI, the ECD-Score and the D-MELD-Score all fail to predict short-term outcome after liver transplantation with acceptable overall model correctness in a current European transplant setting.

摘要

背景

通过使用具有扩展供体标准的移植物来扩大供体库,可降低等待名单上的死亡率,但肝移植后移植物和患者存活风险会增加。本研究调查了供体风险指数(DRI)、扩展标准供体评分(ECD评分)和D-MELD评分预测肝移植早期结局的能力。

材料/方法:在一项持续收集数据的单中心研究中,分析了291例连续的成人肝移植病例(2007年1月1日至2010年12月31日)。主要研究终点为30天死亡率、3个月死亡率、3个月患者和移植物存活率以及30天内急性再次移植的必要性。对于主要研究终点,进行ROC曲线分析,以计算供体风险指数(DRI)、扩展标准供体评分(ECD评分)和D-MELD评分作为预测模型的敏感性、特异性和总体模型正确性。选择具有最佳约登指数的临界值。

结果

ROC曲线分析显示,作为预测30天死亡率、3个月死亡率、3个月患者存活率、3个月移植物存活率以及移植后30天内急性再次移植必要性的模型,DRI、ECD评分和D-MELD评分的曲线下面积(AUROCs)<0.7,总体模型正确性(<62%)和特异性(<56%)处于不可接受的低水平。

结论

在当前欧洲移植环境中,DRI、ECD评分和D-MELD评分均无法以可接受的总体模型正确性预测肝移植后的短期结局。

相似文献

1
The Donor-Risk-Index, ECD-Score and D-MELD-Score all fail to predict short-term outcome after liver transplantation with acceptable sensitivity and specificity.供体风险指数、ECD评分和D-MELD评分均无法以可接受的敏感性和特异性预测肝移植后的短期预后。
Ann Transplant. 2012 Jul-Sep;17(3):5-13. doi: 10.12659/aot.883452.
2
Value of the SOFA score as a predictive model for short-term survival in high-risk liver transplant recipients with a pre-transplant labMELD score ≥ 30.SOFA 评分作为移植前 labMELD 评分≥30 的高危肝移植受者短期生存预测模型的价值。
Langenbecks Arch Surg. 2012 Jun;397(5):717-26. doi: 10.1007/s00423-011-0881-9. Epub 2011 Dec 6.
3
Utilization of extended donor criteria liver allograft: Is the elevated risk of failure independent of the model for end-stage liver disease score of the recipient?扩大标准供体肝移植的应用:移植失败风险升高是否独立于受者的终末期肝病模型评分?
Transplantation. 2006 Dec 27;82(12):1653-7. doi: 10.1097/01.tp.0000250571.41361.21.
4
Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.终末期肝病模型评分不能预测活体肝移植受者的患者或移植物存活率。
Liver Transpl. 2003 Jul;9(7):737-40. doi: 10.1053/jlts.2003.50122.
5
Should a lower quality organ go to the least sick patient? Model for end-stage liver disease score and donor risk index as predictors of early allograft dysfunction.质量较低的器官应该给病情最轻的患者吗?终末期肝病评分和供体风险指数作为早期移植肝功能障碍预测指标的模型。
Transplant Proc. 2012 Jun;44(5):1303-6. doi: 10.1016/j.transproceed.2012.01.115.
6
The postoperative Model for End stage Liver Disease score as a predictor of short-term outcome after transplantation of extended criteria donor livers.终末期肝病术后模型评分作为扩大标准供肝移植术后短期预后的预测指标。
Eur J Gastroenterol Hepatol. 2017 Jun;29(6):716-722. doi: 10.1097/MEG.0000000000000851.
7
[Extended donor criteria defined by the German Medical Association : study on their usefulness as prognostic model for early outcome after liver transplantation].[德国医学协会定义的扩大供体标准:关于其作为肝移植早期预后预测模型的效用研究]
Chirurg. 2012 Nov;83(11):980-8. doi: 10.1007/s00104-012-2325-7.
8
Value of the preoperative SOFT-score, P-SOFT-score, SALT-score and labMELD-score for the prediction of short-term patient and graft survival of high-risk liver transplant recipients with a pre-transplant labMELD-score ≥30.术前SOFT评分、P-SOFT评分、SALT评分及实验室MELD评分对移植前实验室MELD评分≥30的高危肝移植受者短期患者及移植物存活预测的价值
Ann Transplant. 2012 Apr-Jun;17(2):11-7. doi: 10.12659/aot.883218.
9
Proposal for a New Predictive Model of Short-Term Mortality After Living Donor Liver Transplantation due to Acute Liver Failure.关于活体肝移植治疗急性肝衰竭后短期死亡率新预测模型的提案。
Ann Transplant. 2017 Feb 21;22:101-107. doi: 10.12659/aot.901771.
10
Impact of pretransplant MELD score on posttransplant outcome in orthotopic liver transplantation for patients with acute-on-chronic hepatitis B liver failure.慢性乙型肝炎急性肝衰竭患者原位肝移植中移植前终末期肝病模型(MELD)评分对移植后结局的影响
Transplant Proc. 2007 Jun;39(5):1501-4. doi: 10.1016/j.transproceed.2007.02.070.

引用本文的文献

1
Mitochondrial miR-23b-5p is a new biomarker of warm ischaemic injury in donor livers and a candidate for graft evaluation: experimental studies.线粒体 miR-23b-5p 是供体肝脏热缺血损伤的新型生物标志物,也是评估移植物的候选物:实验研究。
Int J Surg. 2023 Jul 1;109(7):1880-1892. doi: 10.1097/JS9.0000000000000263.
2
Development of a Novel Model for Predicting Postoperative Short-Term Outcome in Patients with Hepatitis B-Related Acute-on-Chronic Liver Failure Undergoing Liver Transplantation.开发一种新模型预测乙型肝炎相关慢加急性肝衰竭患者肝移植术后短期预后
Ann Transplant. 2022 Aug 26;27:e936732. doi: 10.12659/AOT.936732.
3
Development of a Novel Prognostic Nomogram for High Model for End-Stage Liver Disease Score Recipients Following Deceased Donor Liver Transplantation.
开发一种用于预测终末期肝病模型评分高的死者供肝肝移植受者预后的新型列线图。
Front Med (Lausanne). 2022 Mar 3;9:772048. doi: 10.3389/fmed.2022.772048. eCollection 2022.
4
A Clinical Tool to Guide Selection and Utilization of Marginal Donor Livers With Graft Steatosis in Liver Transplantation.一种指导肝移植中选择和使用伴有移植物脂肪变性的边缘供肝的临床工具。
Transplant Direct. 2022 Jan 13;8(2):e1280. doi: 10.1097/TXD.0000000000001280. eCollection 2022 Feb.
5
The liver transplant risk score prognosticates the outcomes of liver transplant recipients at listing.肝移植风险评分可预测肝移植受者的预后。
HPB (Oxford). 2021 Jun;23(6):927-936. doi: 10.1016/j.hpb.2020.10.002. Epub 2020 Nov 11.
6
Preoperative Stratification of Liver Transplant Recipients: Validation of the LTRS.肝移植受者术前分层:LTRS 的验证。
Transplantation. 2020 Dec;104(12):e332-e341. doi: 10.1097/TP.0000000000003353.
7
Liver Grafts with Major Extended Donor Criteria May Expand the Organ Pool for Patients with Hepatocellular Carcinoma.具有主要扩大供体标准的肝脏移植物可能会扩大肝细胞癌患者的器官库。
J Clin Med. 2019 Oct 15;8(10):1692. doi: 10.3390/jcm8101692.
8
Predictive Capacity of Risk Models in Liver Transplantation.肝移植中风险模型的预测能力
Transplant Direct. 2019 May 22;5(6):e457. doi: 10.1097/TXD.0000000000000896. eCollection 2019 Jun.
9
Prediction of Perioperative Mortality of Cadaveric Liver Transplant Recipients During Their Evaluations.预测尸肝移植受者评估期间的围手术期死亡率。
Transplantation. 2019 Oct;103(10):e297-e307. doi: 10.1097/TP.0000000000002810.
10
Liver transplantation for critically ill cirrhotic patients: Overview and pragmatic proposals.肝移植治疗危重症肝硬化患者:概述与实用建议。
World J Gastroenterol. 2018 Dec 14;24(46):5203-5214. doi: 10.3748/wjg.v24.i46.5203.